panaxadiol has been researched along with Innate Inflammatory Response in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jin, HL; Jin, X; Lee, JJ; Li, MY; Ma, J; Wang, JY; Xing, Y; Zhang, ZH; Zhong, Y; Zuo, HX | 1 |
| Fan, G; Liang, Y; Yue, S; Zhang, H; Zhang, M; Zhu, J | 1 |
2 other study(ies) available for panaxadiol and Innate Inflammatory Response
| Article | Year |
|---|---|
Panaxadiol inhibits IL-1β secretion by suppressing zinc finger protein 91-regulated activation of non-canonical caspase-8 inflammasome and MAPKs in macrophages.
Topics: Animals; Anti-Inflammatory Agents; Caspase 8; Colitis; Gene Knockdown Techniques; Ginsenosides; HEK293 Cells; Humans; Inflammasomes; Inflammation; Interleukin-1beta; Macrophages; Male; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Molecular Docking Simulation; Neuroprotective Agents; Panax; THP-1 Cells; Ubiquitin-Protein Ligases | 2022 |
Combination of Panaxadiol and Panaxatriol Type Saponins and Ophioponins From Shenmai Formula Attenuates Lipopolysaccharide-induced Inflammatory Injury in Cardiac Microvascular Endothelial Cells by Blocking NF-kappa B Pathway.
Topics: Animals; Cells, Cultured; Drug Combinations; Drug Therapy, Combination; Drugs, Chinese Herbal; Endothelial Cells; Ginsenosides; Inflammation; Inflammation Mediators; Lipopolysaccharides; Microvessels; NF-kappa B; Ophiopogon; Rats; Rats, Wistar; Saponins; Signal Transduction | 2017 |